Week in Review: AI reimbursement proves tricky | Irish row rumbles on | Cannabis and the brain

Dear AuntMinnieEurope Member,

It's not exactly rocket science, but until reimbursement issues are sorted out, widespread implementation of radiology AI is very unlikely to happen.

Industry analyst Sanjay Parekh, PhD, who recently moved from Signify Research to Perspectum, has addressed this subject in a new viewpoint column. Make sure you read his words of wisdom.

Dr. Martin Schranz, the senior radiologist suspended by University Hospital Kerry, will not be silenced, it seems. Our report posted on Tuesday is by far this week's most viewed article.  According to the latest reports in the Irish media, a local general practitioner has spoken out strongly in support of Schranz, who is now due to meet with hospital management for talks. Watch this space for further updates.

Cannabis use in New Zealand is widespread, particularly among teenagers and 20-somethings, even though the drug remains illegal following a national referendum in 2020. An MRI study into the impact of cannabis on the aging brain has provoked great interest, as Rebecca Lee explained to me in a video interview we recorded on Monday.

In other news, Danish researchers have developed a virtual reality test that enables a standardized, objective, and evidence-based approach to assessment of thoracic ultrasound skills. They unveiled their findings on 6 January in Ultrasound in Medicine & Biology.

It's extremely hard to even contemplate ECR 2026 right now, but the race is now on to determine the presidency of this congress. The person will either be Spanish or Dutch. ESR members will decide in this month's vote.

Philip Ward
Editor in Chief

Page 1 of 1240
Next Page